Endeavour Obtains Interim Stock and Claims Order for Trading Requirements
PR Newswire - Fri Oct 17, 4:45PM CDT
Endeavour International Corporation (OTC: ENDRQ) (LSE: ENDV) announced today that on October 10, 2014, it and certain of its subsidiaries, including Endeavour Operating Corporation (collectively, the "Debtors"
END: 0.16 (-0.03)
Endeavour Announces Rochelle Field Has Returned to Production
PR Newswire - Wed Oct 15, 9:30AM CDT
Endeavour International Corporation (OTC Pink: ENDRQ) (LSE: ENDV) today announced that the Rochelle field is back online. Production from the field restarted on October 12, 2014 and is currently producing at 90 million standard cubic feet of gas per day ("MMscf/d"
END: 0.16 (-0.03)
Endeavour Executes Restructuring Support Agreement Pursuant to Chapter 11 Proceedings
PR Newswire - Fri Oct 10, 10:51PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company has executed a Restructuring Support Agreement ("RSA"
END: 0.16 (-0.03)
Endeavour Announces One Day Forbearance Agreement with Noteholders
PR Newswire - Thu Oct 09, 8:00PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company and certain of its subsidiaries have entered into extensions of their forbearance agreements (the "Forbearance Agreements"
END: 0.16 (-0.03)
Endeavour Announces the Appointment of a Chief Restructuring Officer
PR Newswire - Mon Oct 06, 4:00PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Company has engaged Opportune LLP, to assist the company in its financial restructuring process. In connection with this engagement, David C. Baggett, Managing Partner of Opportune LLP, has been appointed as Chief Restructuring Officer of Endeavour, effective immediately, reporting directly to the Board of Directors.
END: 0.16 (-0.03), GEL: 47.84 (-0.64)
Endeavour International Corporation Announces Closing of $440 Million Senior Secured First Lien Term Loan and Forbearance Agreement with Noteholders
PR Newswire - Wed Oct 01, 1:00AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced the closing of a $440 million senior secured term loan (the "Credit Agreement"
END: 0.16 (-0.03)
Endeavour Announces Rochelle Field Remains Offline
PR Newswire - Fri Sep 26, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has been informed by the operator of the Scott platform that the Rochelle field remains offline. Although the repairs of the Scott export compressors were successfully completed, the gas cooler failed a leak test during commissioning.
END: 0.16 (-0.03)
Endeavour Receives Notice Regarding NYSE Continued Listing Standards
PR Newswire - Wed Sep 17, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) announced today that the New York Stock Exchange ("NYSE"
END: 0.16 (-0.03)
Endeavour Announces Rochelle Field Offline
PR Newswire - Mon Sep 15, 3:30PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that the Rochelle field is offline until repairs to the dry gas export compressors on the Scott platform are completed.
END: 0.16 (-0.03)
Endeavour Announces Decision Not to Make Interest Payments
PR Newswire - Tue Sep 02, 3:05PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has decided not to pay approximately $33.5 million in interest due on September 2, 2014 on its 12% First Priority Notes due March 2018, 12% Second Priority Notes due June 2018 and 6.5% Convertible Senior Notes due November 2017 ("collectively, the Notes"
END: 0.16 (-0.03)
Endonovo Therapeutics Files Patent on Bioelectronic Technology, Devices and Therapies
Marketwire - Tue Sep 02, 8:02AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV), a developer of novel cell-free therapies, announced today that it has filed a patent on bioelectronic technologies, devices and therapies (the "Technology"
Endonovo Therapeutics Developing Non-Invasive Bioelectronic Therapy for Urinary Incontinence
Marketwire - Thu Aug 14, 8:03AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"
Endeavour to Present at EnerCom's The Oil and Gas Conference
PR Newswire - Tue Aug 12, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at EnerCom's The Oil and Gas Conference being held in Denver, Colorado. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Wednesday, August 20, 2014 at 10:05am Mountain time.
END: 0.16 (-0.03)
Endeavour Announces 2014 Second Quarter Financial and Operational Results
PR Newswire - Tue Aug 05, 1:00AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported physical production for the quarter that exceeded the Company's revised guidance range of 10,500 - 11,500 barrels of oil equivalent per day ("boepd"
END: 0.16 (-0.03)
Endeavour Schedules 2014 Second Quarter Conference Call and Webcast
PR Newswire - Mon Jul 28, 4:37PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) will host a conference call and webcast to discuss its 2014 second quarter financial and operating results on Tuesday, August 5, 2014 at 9 a.m. Central Time, 3 p.m. British Summer Time.
END: 0.16 (-0.03)
Endeavour to Present at the Howard Weil Energy Conference
PR Newswire - Tue Mar 25, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at the Howard Weil's 42nd Annual Energy Conference. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Thursday, March 27, 2014 at 11:00 am Central time.
END: 0.16 (-0.03)
Endeavour Announces New Board Member
PR Newswire - Wed Mar 19, 3:29PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that James H. Browning has been appointed to a serve as a Director on the company's Board of Directors. He will serve as an independent director and be appointed to both the Technology & Reserves Committee and Audit Committee, where he qualifies as an "audit committee financial expert."
END: 0.16 (-0.03)
Endeavour Announces 2013 Fourth Quarter and Year-End Financial and Operational Results
PR Newswire - Wed Mar 05, 1:00AM CST
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported fourth quarter 2013 net loss, as adjusted of $24.7 million compared to a net loss, as adjusted of $7.7 million for the same period in 2012. On a GAAP basis, net loss for the fourth quarter was $27.7 million as compared to net loss of $6.5 million for the same quarter in 2012.
END: 0.16 (-0.03)